All questions
Guidelines: Imbruvica (ibrutinib) in chronic lymphocytic leukemia and small lymphocytic lymphoma
1 question · 1 source
Questions that apply to every indication of Imbruvica are on Imbruvica (ibrutinib), all indications.
Guidelines
What do NCCN guidelines say about continuing covalent BTK inhibitors such as Imbruvica?
Note: The statements concern covalent BTK inhibitors (cBTKi) as a class. The page cites the NCCN Clinical Practice Guidelines in Oncology for CLL/SLL, Version 1.2026.